Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans.

Journal Article (Journal Article)

Candida albicans is the most common human fungal pathogen causing mucosal and systemic infections. However, human antifungal immunity remains poorly defined. Here by integrating transcriptional analysis and functional genomics, we identified Candida-specific host defence mechanisms in humans. Candida induced significant expression of genes from the type I interferon pathway in human peripheral blood mononuclear cells. This unexpectedly prominent role of type I interferon pathway in anti-Candida host defence was supported by additional evidence. Polymorphisms in type I interferon genes modulated Candida-induced cytokine production and were correlated with susceptibility to systemic candidiasis. In in vitro experiments, type I interferons skewed Candida-induced inflammation from a Th17 response towards a Th1 response. Patients with chronic mucocutaneous candidiasis displayed defective expression of genes in the type I interferon pathway. These findings indicate that the type I interferon pathway is a main signature of Candida-induced inflammation and has a crucial role in anti-Candida host defence in humans.

Full Text

Duke Authors

Cited Authors

  • Smeekens, SP; Ng, A; Kumar, V; Johnson, MD; Plantinga, TS; van Diemen, C; Arts, P; Verwiel, ETP; Gresnigt, MS; Fransen, K; van Sommeren, S; Oosting, M; Cheng, S-C; Joosten, LAB; Hoischen, A; Kullberg, B-J; Scott, WK; Perfect, JR; van der Meer, JWM; Wijmenga, C; Netea, MG; Xavier, RJ

Published Date

  • 2013

Published In

Volume / Issue

  • 4 /

Start / End Page

  • 1342 -

PubMed ID

  • 23299892

Pubmed Central ID

  • PMC3625375

Electronic International Standard Serial Number (EISSN)

  • 2041-1723

Digital Object Identifier (DOI)

  • 10.1038/ncomms2343


  • eng

Conference Location

  • England